Placemark Investments’s Eli Lilly LLY Stock Holding History

Placemark Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$12.9M	Sell	186,560 -11,129	-6%	-$751K	0.23%	104
2014 Q3	$12.8M	Buy	197,689 +33,308	+20%	+$2.11M	0.24%	93
2014 Q2	$10.2M	Buy	164,381 +4,695	+3%	+$280K	0.18%	121
2014 Q1	$9.4M	Buy	159,686 +754	+0.5%	+$42.1K	0.18%	128
2013 Q4	$8.11M	Sell	158,932 -101,016	-39%	-$5.06M	0.13%	188
2013 Q3	$13.1M	Buy	259,948 +22,381	+9%	+$1.17M	0.25%	90
2013 Q2	$11.7M	Buy	+237,567	New	+$12.9M	0.25%	99

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Placemark Investments's LLY Position: Q4 2014 in Review

Placemark Investments reduced its Eli Lilly (LLY) stake by 5.6% in Q4 2014, selling an estimated $751K and leaving 186,560 shares worth $12.9M. The position accounts for 0.23% of the portfolio, ranked #104.

Placemark Investments first reported a position in LLY in Q2 2013 and has held it in 7 quarters since. The position peaked at $13.1M in Q3 2013. 1,129 funds tracked by Wall St. Rank hold LLY as of Q4 2014.

Placemark Investments held 186,560 shares of Eli Lilly worth $12.9M as of Q4 2014.
Placemark Investments sold 11,129 Eli Lilly shares in Q4 2014, an estimated $751K.
Eli Lilly made up 0.23% of Placemark Investments's portfolio in Q4 2014, its #104 holding.
Placemark Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's Eli Lilly position peaked at $13.1M in Q3 2013.
1,129 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.